SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

The company witnessed a 7.94% growth in the revenue at Rs. 1523.57 millions for the quarter ended December 2022 as compared to Rs. 1411.53 millions during the year-ago period.A slim rise of 14.44% was recorded in the Net profit for the quarter ended December 2022 to Rs. 222.82  millions  From Rs. 194.70 millions.Operating Profit saw a handsome growth to 338.14 millions from 313.18 millions in the quarter ended December 2022.


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202212 202112 % Var 202212 202112 % Var 202203 202103 % Var
Sales 1523.57 1411.53 7.94 4303.51 3765.91 14.28 5201.35 3406.08 52.71
Other Income 30.19 13.92 116.88 44.92 25.87 73.64 27.62 13.30 107.67
PBIDT 338.14 313.18 7.97 863.35 819.75 5.32 1079.38 815.32 32.39
Interest 11.88 3.38 251.48 18.19 58.19 -68.74 64.07 56.18 14.04
PBDT 326.26 309.80 5.31 845.16 761.56 10.98 1015.31 759.14 33.74
Depreciation 30.59 24.23 26.25 89.16 69.68 27.96 100.80 41.88 140.69
PBT 295.67 285.57 3.54 756.00 691.88 9.27 914.51 717.26 27.50
TAX 72.85 90.87 -19.83 194.17 185.23 4.83 195.04 177.27 10.02
Deferred Tax 8.25 17.06 -51.64 19.09 27.35 -30.20 27.83 1.63 1607.36
PAT 222.82 194.70 14.44 561.83 506.65 10.89 719.47 539.99 33.24
Equity 364.37 364.37 0.00 364.37 364.37 0.00 364.37 315.00 15.67
PBIDTM(%) 22.19 22.19 0.03 20.06 21.77 -7.84 20.75 23.94 -13.31

Acutaas Chemicals Share Price

2386.55 -35.95 (-1.48%)
23-Apr-2026 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1679.85
Dr. Reddys Lab 1333.05
Cipla 1305.85
Zydus Lifesciences 947.10
Lupin 2340.20
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×